Johnson & Johnson (NYSE:JNJ)

101.65
Delayed Data
As of Mar 04
 -0.69 / -0.67%
Today’s Change
92.25
Today|||52-Week Range
109.49
-2.79%
Year-to-Date
Benzinga's M&A Chatter for Wednesday March 4, 2015
Mar 04 / Benzinga
Cramer: Pharmacyclics-Johnson & Johnson Deal Unlikely at This Price
Feb 27 / TheStreet.com
Report: Pharmacyclics Inc. To Be Acquired By Johnson & Johnson
Mar 04 / Benzinga
3 Dividend Aristocrats We Want to Own
Feb 27 / MotleyFool.com
Fast Money Halftime Report Final Trade From March 4
Mar 04 / Benzinga
The Best All-Around Stock in the Market
Feb 27 / MotleyFool.com
J&J nears deal for cancer drugmaker
Mar 04 / FT.com
Dow Jones (DJIA) Today: Johnson & Johnson (JNJ) Leads The Day Higher, Chevron (CVX) L...
Feb 26 / TheStreet.com
Apple Inc., Microsoft Corporation, Google Inc: Are We Witnessing A New Tech Bubble?
Mar 04 / Investing Channel
Search Is Endless for Great Stocks
Feb 26 / TheStreet.com
Geron's Q4 Loss Narrows Y/Y, Announces Restructuring Plan - Analyst Blog
Mar 04 / Zacks.com
The single best stock to own today
Feb 26 / CNNMoney.com
These ads ran before ISIS videos
Mar 03 / CNNMoney.com
Pharmacyclics (PCYC) Jumps 16.9% on Takeover Rumors - Analyst Blog
Feb 26 / Zacks.com
Cardinal Health Set to Buy Cordis, Shares Hit 52-Week High - Analyst Blog
Mar 03 / Zacks.com
Frontrunning: February 26
Feb 26 / Investing Channel
Halozyme Q4 Loss Narrower-than-Expected, Revenues Up - Analyst Blog
Mar 03 / Zacks.com
Pharmacyclics considers $19bn sale
Feb 25 / FT.com
Stock Market News for March 03, 2015 - Market News
Mar 03 / Zacks.com
Why Pharmacyclics, Inc. Soared Higher Today
Feb 25 / MotleyFool.com
Guess Which Company Just Toppled Amazon.com Inc's Top Spot For Business Reputation
Mar 03 / MotleyFool.com
Hospira and Celltrion launch biosimilars
Feb 24 / FT.com
Is Xoma Corporation A Buy?
Mar 03 / MotleyFool.com
Why Depomed Inc. Sky-Rocketed Today
Feb 24 / MotleyFool.com
Benzinga's M&A Chatter for Monday March 2, 2015
Mar 02 / Benzinga
Apple eyes trillion-dollar market cap
Feb 24 / FT.com
Cardinal Health Acquires Johnson & Johnson's Cordis in a $1.9 Billion Deal
Mar 02 / TheStreet.com
There Are Crazy Valuations, and Then There Are the Valuations of These 3 Stocks
Feb 22 / MotleyFool.com
Is Fake Wood Flooring From China Killing You or Your Investments?
Mar 02 / TheStreet.com
Why Microsoft's Massive Debt Sale Is a Savvy Move
Feb 22 / MotleyFool.com
'Merger Monday' Lives Up To Name: From NXP Semiconductors To eBay, There's At Least $...
Mar 02 / Benzinga
The $10 Billion Reason That This Tiny Biotech Stock Could Soar
Feb 22 / MotleyFool.com
What's in Store for Geron (GERN) this Earnings Season? - Analyst Blog
Mar 02 / Zacks.com
3 Proven Ways to Get More Income in Retirement
Feb 21 / MotleyFool.com
3 Stocks Moving The Drugs Industry Upward
Mar 02 / TheStreet.com
Boston Scientific Settles $7.2B J&J Suit for $600M, Stock Up - Analyst Blog
Feb 19 / Zacks.com
GSK-Novartis deal 'a model' for industry
Mar 02 / FT.com
Pharmacyclics Misses on Q4 Earnings, Reiterates 2015 View - Analyst Blog
Feb 19 / Zacks.com
Stock Market News for March 02, 2015 - Market News
Mar 02 / Zacks.com
Compound sharing boosts drugs success
Feb 16 / FT.com
UPDATE: Johnson & Johnson Announces Binding Offer from Cardinal Health to Acquire Cor...
Mar 02 / Benzinga
Greed is back! S&P 500 sets new record high
Feb 13 / CNNMoney.com
3 Big Cap Biotechs That Could Trounce Gilead Sciences This Year
Mar 01 / MotleyFool.com
 Strong dollar won't hurt these stocks
Feb 04 / CNNMoney.com
3 Stocks That Could Lose You a Lot of Money
Feb 27 / MotleyFool.com
Strong dollar winners: All-American stocks
Feb 04 / CNNMoney.com

To view my watchlist

Not a member yet?

Sign up now for a free account